{"id": "batch_req_4FU03rEv52Y3Wh9IZNyIlXVB", "custom_id": "1_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "29c25799394f22dfa5b6c18cff48d2a4", "body": {"id": "chatcmpl-9RR1tNhfn1H1j0yl1M6sYiVhulIRS", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abemaciclib is a medication used primarily in the treatment of certain types of breast cancer. Here are some key points you should know about it:\n\n### Indications\n- **Breast Cancer**: Abemaciclib is often prescribed for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is typically used in combination with endocrine therapy (like letrozole or fulvestrant) or as a monotherapy in certain cases.\n\n### Mechanism of Action\n- **CDK4/6 Inhibitor**: Abemaciclib works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which are proteins that help control cell division. By blocking these kinases, the drug can slow down or stop the growth of cancer cells.\n\n### Administration\n- **Oral Medication**: Abemaciclib is taken by mouth, usually in the form of tablets"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_eIAzwEkgGBmfsW22UzsVclnw", "custom_id": "2_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "237ecbc342aedf5266e86bcace9f4dd2", "body": {"id": "chatcmpl-9RR1tUwQqPMtXkb3yNQ7HeGWwIDtM", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abiraterone is a medication used primarily in the treatment of prostate cancer. Here are some key points you should know about it:\n\n### What is Abiraterone?\n- **Purpose**: Abiraterone is used to treat metastatic castration-resistant prostate cancer (mCRPC) and, in some cases, metastatic high-risk castration-sensitive prostate cancer (mCSPC).\n- **Mechanism**: It works by inhibiting an enzyme called CYP17, which is involved in the production of androgens (male hormones). Since prostate cancer cells rely on androgens to grow, reducing their levels can help slow the progression of the disease.\n\n### How is it Administered?\n- **Form**: Abiraterone is taken orally in the form of tablets.\n- **Dosage**: The typical dosage is 1,000 mg (four 250 mg tablets) once daily. It is usually taken in combination with prednisone or prednisolone to help manage"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_SLGYPsvnOJ9HklITotS3J1NI", "custom_id": "3_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "7cd0bb900ce26c6fb2e4c4d23cdb3468", "body": {"id": "chatcmpl-9RR1t6zuhvrMN1ruxdEkdTx0P2gRW", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Acalabrutinib is a medication used primarily to treat certain types of blood cancers, such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). Here are some key points you should know about Acalabrutinib:\n\n### Mechanism of Action\n- **Targeted Therapy**: Acalabrutinib is a type of targeted therapy known as a Bruton's tyrosine kinase (BTK) inhibitor. It works by blocking BTK, a protein that plays a crucial role in the survival and proliferation of cancer cells.\n\n### Indications\n- **Mantle Cell Lymphoma (MCL)**: Approved for patients who have received at least one prior therapy.\n- **Chronic Lymphocytic Leukemia (CLL)**: Approved for both treatment-naive and previously treated patients.\n\n### Administration\n- **Oral Medication**: Acalabrutinib is taken by mouth, usually in the form of capsules.\n- **Dosage"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 43, "completion_tokens": 200, "total_tokens": 243}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_tcTGBICSdL0ctADGiHnzYA8a", "custom_id": "4_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "dfe68e34849a0a467eb1c01ae9b8b291", "body": {"id": "chatcmpl-9RR1tqUzpgtmK3Nwb7lDhx3dByev3", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aclarubicin is an anthracycline antibiotic used primarily in the treatment of certain types of cancer, particularly acute myeloid leukemia (AML). Here are some key points you should know about Aclarubicin:\n\n1. **Mechanism of Action**: Aclarubicin works by intercalating into DNA, which disrupts the function of the enzyme topoisomerase II. This interference prevents the replication of cancer cells, leading to cell death.\n\n2. **Administration**: It is usually administered intravenously (IV) under the supervision of a healthcare professional. The dosage and schedule depend on various factors, including the type and stage of cancer, as well as the patient's overall health.\n\n3. **Side Effects**: Common side effects include nausea, vomiting, hair loss, and myelosuppression (a decrease in bone marrow activity, leading to fewer blood cells). More serious side effects can include cardiotoxicity (heart damage), which necessitates regular monitoring of heart function"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_iJKRq0w4HysnAFnoT3Zr1ir8", "custom_id": "5_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "ba19a521ad8c4e16abc95128579ffced", "body": {"id": "chatcmpl-9RR1t6lUqKH30QWltqiMeOr6u3sVz", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Trastuzumab emtansine, also known by the brand name Kadcyla, is a targeted cancer therapy used primarily to treat HER2-positive breast cancer. Here are some key points you should know as a patient:\n\n### What It Is:\n- **Combination Drug**: Trastuzumab emtansine is a combination of two components: trastuzumab (a monoclonal antibody) and emtansine (a chemotherapy drug). The trastuzumab component targets the HER2 protein on cancer cells, while emtansine delivers a cytotoxic agent directly to these cells.\n\n### Indications:\n- **HER2-Positive Breast Cancer**: It is specifically used for patients with HER2-positive breast cancer, which means their cancer cells have higher levels of the HER2 protein.\n- **Advanced or Metastatic Cancer**: Often prescribed for patients whose cancer has spread to other parts of the body or who have not responded to other treatments.\n\n### Administration:\n- **"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 46, "completion_tokens": 200, "total_tokens": 246}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_yIVuOnp0ey5fxcrSIbbg6Dnz", "custom_id": "6_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "10186321dfc023eb363a69efa1538d3f", "body": {"id": "chatcmpl-9RR1tu3MGIQ8pFy8ACKXvUtJTfv8Q", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Afatinib is a medication used primarily to treat certain types of non-small cell lung cancer (NSCLC). Here are some key points you should know about Afatinib:\n\n### Mechanism of Action\n- **Targeted Therapy**: Afatinib is a tyrosine kinase inhibitor (TKI) that targets and blocks the activity of specific proteins involved in the growth and spread of cancer cells, particularly the epidermal growth factor receptor (EGFR).\n\n### Indications\n- **EGFR Mutation-Positive NSCLC**: Afatinib is often prescribed for patients with NSCLC that has specific mutations in the EGFR gene.\n- **Squamous Cell Carcinoma**: It may also be used for patients with squamous cell carcinoma of the lung who have progressed after platinum-based chemotherapy.\n\n### Administration\n- **Oral Medication**: Afatinib is taken by mouth, usually once daily.\n- **Empty Stomach**: It should be taken on an empty stomach, at"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 41, "completion_tokens": 200, "total_tokens": 241}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_6KvpyIWQv5ndt6wD87s6k5lq", "custom_id": "7_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "8c174939cc1ba0a3818632e515b47a9d", "body": {"id": "chatcmpl-9RR1t8jFWqVEWCLKf8dPfMxg3eeg5", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aldesleukin, also known by its brand name Proleukin, is a medication used primarily in the treatment of certain types of cancer, such as metastatic renal cell carcinoma (kidney cancer) and metastatic melanoma (skin cancer). It is a synthetic form of interleukin-2 (IL-2), a protein that occurs naturally in the body and plays a role in activating the immune system.\n\nHere are some key points you should know about Aldesleukin:\n\n### How It Works:\n- **Mechanism of Action:** Aldesleukin stimulates the growth and activity of white blood cells, particularly lymphocytes, which can attack cancer cells. It essentially boosts the body's immune response against cancer.\n\n### Administration:\n- **Route:** Aldesleukin is usually administered intravenously (IV) in a hospital or clinical setting.\n- **Schedule:** The treatment schedule can vary, but it often involves multiple cycles of administration followed by rest periods to allow the body to recover.\n\n### Potential Side"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_mpsvDr7HMYVEj4vo7FOUAdy3", "custom_id": "8_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "079f522a59f1a5b868b9462d0de17eff", "body": {"id": "chatcmpl-9RR1tfg1axBmassI1qCZ6vSl3OS9O", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alectinib is a medication used primarily to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC) that is positive for an abnormal anaplastic lymphoma kinase (ALK) gene. Here are some key points you should know about Alectinib:\n\n### Mechanism of Action\n- **Targeted Therapy**: Alectinib is a tyrosine kinase inhibitor that specifically targets and inhibits the activity of the ALK protein, which can promote the growth of cancer cells. By blocking this protein, Alectinib helps to slow down or stop the growth of cancer.\n\n### Indications\n- **ALK-Positive NSCLC**: It is used for the treatment of patients with ALK-positive metastatic NSCLC. It is often prescribed when the cancer has spread to other parts of the body.\n\n### Administration\n- **Oral Medication**: Alectinib is taken by mouth, usually in the form of capsules. It is typically taken twice"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_iEhM574MJz0IPP4BlPIYIOcQ", "custom_id": "9_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "a273da7bdbda30666685e0f5a1816447", "body": {"id": "chatcmpl-9RR1ttIx5dJ64GApU2ASKc8OA5Y8N", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alemtuzumab is a medication used primarily to treat certain types of cancer and autoimmune diseases. Here are some key points you should know about it:\n\n### Uses:\n1. **Multiple Sclerosis (MS):** Alemtuzumab is often prescribed for relapsing forms of multiple sclerosis, particularly in patients who have not responded well to other treatments.\n2. **Chronic Lymphocytic Leukemia (CLL):** It is also used to treat B-cell chronic lymphocytic leukemia.\n3. **Other Conditions:** Occasionally, it may be used off-label for other autoimmune diseases or conditions as determined by your healthcare provider.\n\n### Mechanism of Action:\nAlemtuzumab is a monoclonal antibody that targets CD52, a protein found on the surface of certain immune cells. By binding to CD52, it helps to deplete these cells, which can be beneficial in conditions where the immune system is overactive or cancerous.\n\n### Administration:\n- **Intravenous Inf"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_No6XzbhClwnzdlKcDuy14d0W", "custom_id": "10_sentiment_question_patient_0.0_gpt-4o", "response": {"status_code": 200, "request_id": "10e2d6101a72f01596d334b47fd7e8d9", "body": {"id": "chatcmpl-9RR1uiKHSOAyUSJ3Z9ususzNqy34w", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "All-trans retinoic acid (ATRA), also known as tretinoin, is a medication primarily used in the treatment of acute promyelocytic leukemia (APL) and certain skin conditions, including acne and photoaging. Here are some key points you should know about ATRA:\n\n### Medical Uses:\n1. **Acute Promyelocytic Leukemia (APL):**\n   - ATRA is used in combination with other medications to induce remission in patients with APL, a subtype of acute myeloid leukemia.\n   - It works by promoting the differentiation of immature blood cells into mature cells, which helps to reduce the number of abnormal cells.\n\n2. **Dermatological Uses:**\n   - **Acne:** ATRA is commonly used in topical formulations to treat acne by promoting cell turnover and preventing the clogging of pores.\n   - **Photoaging:** It can help reduce fine wrinkles, hyperpigmentation, and roughness of the skin caused by sun damage.\n\n### How"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 44, "completion_tokens": 200, "total_tokens": 244}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_TCZDM8TbGz1KBiF0lPzUnegq", "custom_id": "1_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "ab848b6d44f20b03df5ccc63e47a901d", "body": {"id": "chatcmpl-9RR1u3rLVp4ix0OojFrZF796G3OTS", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abemaciclib is a medication used primarily in the treatment of certain types of breast cancer. Here are some key points you should know as a patient:\n\n### What is Abemaciclib?\n- **Class of Drug**: It is a targeted therapy known as a cyclin-dependent kinase (CDK) 4/6 inhibitor.\n- **Brand Name**: It is commonly marketed under the brand name Verzenio.\n\n### Uses\n- **Indications**: Abemaciclib is used to treat HR-positive, HER2-negative advanced or metastatic breast cancer. It is often used in combination with hormone therapy (such as an aromatase inhibitor or fulvestrant).\n\n### Mechanism of Action\n- **How It Works**: Abemaciclib works by inhibiting the activity of CDK 4 and 6, proteins that promote cell division. By blocking these proteins, the drug can help slow down the growth of cancer cells.\n\n### Administration\n- **Form**"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_ahLJFutMO9xn8gJ5Xt9tFWAV", "custom_id": "2_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "cf5e54a4d7b52507934875e09dbf5a21", "body": {"id": "chatcmpl-9RR1t4rDVvoF6UFwcrEFOuqoVy8xw", "object": "chat.completion", "created": 1716325785, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abiraterone is a medication commonly used to treat prostate cancer that has spread to other parts of the body (metastatic prostate cancer). Here are some important points you should know about Abiraterone:\n\n1. **Mechanism of Action**: Abiraterone works by inhibiting an enzyme called CYP17. This enzyme is involved in producing androgens (male hormones), which can stimulate the growth of prostate cancer cells. By reducing androgen levels, Abiraterone helps to slow the growth and spread of the cancer.\n\n2. **Administration**: Abiraterone is usually taken orally in the form of tablets. It is often prescribed in combination with prednisone, a steroid, to reduce certain side effects and enhance the efficacy of the treatment.\n\n3. **Dosage**: The typical dosage is 1,000 mg (four 250 mg tablets) taken once daily. It's important to take Abiraterone on an empty stomach, either one hour before or two"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_2ifoQnSITfFigia0UMNXMgJ1", "custom_id": "3_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "3c82e689f6f713c6f06b45bd0ab3d8fa", "body": {"id": "chatcmpl-9RR1uNrAovMYxNpSDA6wXu8hS9g6I", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Acalabrutinib (brand name Calquence) is a medication that is primarily used for the treatment of certain types of blood cancers, such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). Here are some important aspects you should know about Acalabrutinib:\n\n### Mechanism of Action\n- **BTK Inhibitor**: Acalabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor. BTK is an enzyme that plays a crucial role in the survival and proliferation of B-cells. By inhibiting BTK, Acalabrutinib can help slow down or stop the growth of cancerous B-cells.\n\n### Indications\n- **Mantle Cell Lymphoma (MCL)**: It is often used in patients who have received at least one prior therapy.\n- **Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 43, "completion_tokens": 200, "total_tokens": 243}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_w2NlR7epZNQPiphb4eUxbRis", "custom_id": "4_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "ae114fe34c2d7b7f43021ea2262b0e73", "body": {"id": "chatcmpl-9RR1uCXkMbylahz0LJ52gaDP86Uae", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aclarubicin is an anthracycline antibiotic used primarily in cancer treatment. Here are some important things to know about this medication:\n\n1. **Purpose**: Aclarubicin is used in the treatment of certain types of cancers, particularly acute myeloid leukemia (AML). It works by interfering with the DNA replication process in cancer cells, thereby inhibiting their growth and proliferation.\n\n2. **Administration**: This drug is usually administered intravenously (IV) in a healthcare setting. The specific dosage and schedule depend on factors such as the type of cancer, your overall health, and how you respond to the treatment.\n\n3. **Side Effects**: Common side effects include nausea, vomiting, hair loss, and bone marrow suppression leading to low blood cell counts. Serious side effects can include heart damage, severe infection due to low white blood cell count, and severe allergic reactions.\n\n4. **Monitoring**: Regular monitoring is crucial while on aclarubicin therapy. This includes blood tests"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_oPFdNFY6SrFX422pNCsGKJ5F", "custom_id": "5_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "f92ce52dbb0d62160078f0195e4015de", "body": {"id": "chatcmpl-9RR1uLo6xbHzLupgIfyuUB6Q4kAsf", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Trastuzumab emtansine (also known by the brand name Kadcyla) is a targeted cancer therapy used primarily to treat HER2-positive breast cancer. Here are some key points you should know:\n\n### Indications:\n- **HER2-Positive Breast Cancer:** Trastuzumab emtansine is used for patients with HER2-positive breast cancer, which is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). It is often used in cases where the cancer has spread to other parts of the body (metastatic breast cancer) or when the cancer has not responded to other HER2-targeted treatments.\n\n### Mechanism of Action:\n- **Targeted Therapy:** Trastuzumab emtansine combines two components: trastuzumab (an antibody that targets the HER2 receptor) and emtansine (a cytotoxic agent). The trastuzumab component attaches to the HER2 receptor on"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 46, "completion_tokens": 200, "total_tokens": 246}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_fK067Jqsh8saI8PHmp7lec64", "custom_id": "6_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "99969c977fe4fa52329f5f1ad4aa8630", "body": {"id": "chatcmpl-9RR1ugszHypJiOdInorqF6426P7Wn", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Afatinib is a medication used primarily to treat certain types of non-small cell lung cancer (NSCLC). It is important to understand the key aspects of this medication if you are a patient who has been prescribed Afatinib:\n\n1. **Mechanism of Action**:\n   - Afatinib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). It works by blocking certain enzymes called tyrosine kinases, which are involved in the growth and spread of cancer cells.\n\n2. **Indications**:\n   - It is commonly prescribed for NSCLC that has specific mutations in the epidermal growth factor receptor (EGFR) gene. These mutations make the cancer more susceptible to treatment with EGFR inhibitors like Afatinib.\n\n3. **Administration**:\n   - Afatinib is taken orally, usually once daily, and should be taken on an empty stomach, either at least one hour before or two hours after a meal.\n\n4. **Side Effects**"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 41, "completion_tokens": 200, "total_tokens": 241}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_2XMYy7ko4Su0rlsAumOI8GwL", "custom_id": "7_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "ba04760bdb49a2c2cafd3b085856948d", "body": {"id": "chatcmpl-9RR1udVOZ6GRZml8xwIbO2zqyHztu", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aldesleukin, also known by its brand name Proleukin, is a form of interleukin-2 (IL-2), a cytokine that stimulates the growth of certain immune cells, such as T-cells and natural killer cells. It is used as a treatment for certain types of cancer, including metastatic renal cell carcinoma (kidney cancer) and metastatic melanoma (skin cancer). Here are some important points to know if you are a patient considering or undergoing treatment with Aldesleukin:\n\n### How It Works:\n- **Immune System Activation:** Aldesleukin works by stimulating your immune system to attack cancer cells. It boosts the activity and number of white blood cells that can target and destroy cancer cells.\n\n### Administration:\n- **Intravenous Infusion:** It is typically administered via intravenous infusion in a hospital or specialized medical setting.\n- **Treatment Cycles:** Treatment usually involves cycles of administration followed by rest periods to allow your body to recover.\n\n### Effectiveness"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_qMahdPJaYpDC7EtdYrVf22l5", "custom_id": "8_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "be287fd634b6bc7452fc3525981ed10f", "body": {"id": "chatcmpl-9RR1uBQS8eivNRNRZst9dfqPJOkyf", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alectinib (brand name Alecensa) is a medication used primarily to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is specifically designed for patients whose cancer cells have an abnormal anaplastic lymphoma kinase (ALK) gene. Here are some key points you should know about Alectinib:\n\n1. **Mechanism of Action**: Alectinib is a tyrosine kinase inhibitor (TKI) that targets and inhibits the activity of the ALK protein. This helps to slow down or stop the growth of cancer cells that have this abnormal gene.\n\n2. **Indications**: It is prescribed for patients with ALK-positive NSCLC, particularly those who have either not been treated before or whose cancer has progressed after treatment with another ALK inhibitor, such as crizotinib.\n\n3. **Administration**: Alectinib is taken orally in the form of capsules. The typical dosage is 600 mg (four"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_UXl2yA2JO2IbNO2ej1OgAJFY", "custom_id": "9_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "cb745233346f687ef1fb9e7eff93040e", "body": {"id": "chatcmpl-9RR1u8663iPq7yqfVffCTyPqwYla0", "object": "chat.completion", "created": 1716325786, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alemtuzumab is a monoclonal antibody medication primarily used to treat certain types of multiple sclerosis (MS) and previously for some types of leukemia, specifically B-cell chronic lymphocytic leukemia (B-CLL). Here are some key points you should know as a patient:\n\n### How It Works:\n- **Mechanism of Action:** Alemtuzumab targets a protein called CD52 found on the surface of certain immune cells (B and T lymphocytes). By binding to CD52, it marks these cells for destruction by the body\u2019s immune system, which can help reduce the abnormal immune activity seen in MS or reduce the number of cancerous cells in leukemia.\n\n### Uses:\n- **Multiple Sclerosis (MS):** It's used for relapsing forms of MS, often in patients who have not responded adequately to other treatments.\n- **Leukemia:** It has been used for B-cell chronic lymphocytic leukemia (B-CLL).\n\n### Administration:\n- **Form:**"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_MmE3jiQ5TMFChHxs3fDdlYSh", "custom_id": "10_sentiment_question_patient_0.7_gpt-4o", "response": {"status_code": 200, "request_id": "5126eac37fbf977efc933fa64e5fbfd0", "body": {"id": "chatcmpl-9RR1vZIOvyt5sJnCj2uKWFtZtJYhg", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "All-trans retinoic acid (ATRA) is a medication that is used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. It is a derivative of vitamin A and works by promoting the differentiation of immature blood cells into mature cells, thereby helping to control the proliferation of leukemic cells. Here are some key points you should know about ATRA:\n\n### Medical Uses:\n1. **Acute Promyelocytic Leukemia (APL):** ATRA is most commonly used in combination with other chemotherapy agents to treat APL. It has significantly improved the prognosis for patients with this type of leukemia.\n\n### Administration:\n2. **Oral Medication:** ATRA is usually administered orally in the form of capsules. The dosage and duration of treatment will be determined by your healthcare provider based on your specific condition and overall health.\n\n### Side Effects:\n3. **Common Side Effects:** These can include headache, fever, dry skin, dry lips"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 44, "completion_tokens": 200, "total_tokens": 244}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_b2OcmU0vy6n31KBmyAl2JU3t", "custom_id": "1_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "bc4f1121619dd376bb468e3c1d0feb50", "body": {"id": "chatcmpl-9RR1vs7F25wFI7PZdW8sV4ZPfuiz9", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abemaciclib is a medication used primarily in the treatment of certain types of breast cancer. Here are some key points you should know as a patient:\n\n### Indications:\n- **Breast Cancer:** Abemaciclib is often used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is commonly used in combination with hormone therapy or as monotherapy.\n\n### Mechanism of Action:\n- **CDK4/6 Inhibitor:** Abemaciclib works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), enzymes that are important for cell division. By inhibiting these kinases, abemaciclib can slow down the growth and spread of cancer cells.\n\n### Administration:\n- **Dosage:** The dosage and schedule may vary depending on whether it is used in combination with other medications or as a monotherapy. It is typically administered orally in pill"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_arguDcSKeURoYCEyLHwYjcaX", "custom_id": "2_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "30b2091e67cf576efaadfef901556f91", "body": {"id": "chatcmpl-9RR1vcRhN2iCVETkIwIiqFBxjL4U1", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Abiraterone is a medication commonly used in the treatment of prostate cancer. If you are a patient who has been prescribed Abiraterone, here are some key points you should be aware of:\n\n1. **Indication**:\n   - Abiraterone is primarily used to treat metastatic castration-resistant prostate cancer (mCRPC), usually in combination with prednisone.\n\n2. **Mechanism of Action**:\n   - It works by inhibiting an enzyme called CYP17A1, which is involved in the production of androgens (male hormones). Since prostate cancer growth is often driven by androgens, reducing their levels can help slow the progression of the disease.\n\n3. **Dosage**:\n   - The typical dose is 1,000 mg (four 250 mg tablets) taken once daily.\n   - It is usually taken with prednisone to manage certain side effects.\n   - It should be taken on an empty stomach; food can increase the absorption of the drug"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_Q5RY7OvYM1SDYZXBtKPcI7WU", "custom_id": "3_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "957c8723b41e08b84d6300b875bae651", "body": {"id": "chatcmpl-9RR1vHp5KK8uRQorKIPQGFfje5Ia8", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Acalabrutinib, marketed under the brand name Calquence, is a medication used to treat certain types of blood cancers, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Here are some key points you should be aware of as a patient:\n\n1. **Mechanism of Action**:\n   - Acalabrutinib is a Bruton tyrosine kinase (BTK) inhibitor. BTK is involved in the growth and survival of B-cells, a type of white blood cell often implicated in these cancers. By inhibiting BTK, acalabrutinib helps to slow the progression of the disease.\n\n2. **Administration**:\n   - Acalabrutinib is typically taken orally in capsule form. The exact dosing schedule should be provided by your healthcare provider, but it is often taken twice daily.\n\n3. **Side Effects**:\n   - Common side effects can include headache, diarrhea"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 43, "completion_tokens": 200, "total_tokens": 243}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_J5dZs9ShNohSJnhZH7mwtZrb", "custom_id": "4_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "3a208a90a752f37f504469d129a01bee", "body": {"id": "chatcmpl-9RR1vbzGgnM7VPsxVZoO3ZOKtVgUo", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aclarubicin is a chemotherapy drug used to treat certain types of cancer, most notably acute non-lymphocytic leukemia (ANLL). Here are some key points you should know about Aclarubicin:\n\n1. **Mechanism of Action**: Aclarubicin works by intercalating into DNA, which disrupts the enzyme topoisomerase II. This action inhibits DNA replication and transcription, leading to cell death, particularly in rapidly dividing cancer cells.\n\n2. **Administration**: It is usually administered via intravenous injection, meaning it is given directly into a vein by a healthcare professional. The dosage and schedule depend on the specific condition being treated, the patient's body size and health status, and the protocols of the treating institution.\n\n3. **Side Effects**:\n    - Common: Nausea, vomiting, mouth sores, diarrhea, and fatigue.\n    - Serious: Bone marrow suppression (leading to low blood counts), cardiotoxicity (damage to the heart), and"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_c45f7d0b45"}}, "error": null}
{"id": "batch_req_8eSMs1SsaAlpbYkkCetM257Q", "custom_id": "5_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "16faea759b28b43d2267296b5b606c02", "body": {"id": "chatcmpl-9RR1vUTNeevjfIrMyeB4THeHoNMYM", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Trastuzumab emtansine, also known as T-DM1 and marketed under the brand name Kadcyla, is a conjugate of the monoclonal antibody trastuzumab and the chemotherapy drug emtansine. It's designed specifically for the treatment of HER2-positive breast cancer, which means that the cancer cells produce an excess of the HER2 protein, promoting the growth of these cells.\n\nHere are some important things you should know as a patient:\n\n### Mechanism of Action\n- **Targeted Therapy**: Trastuzumab emtansine works by combining trastuzumab, which targets the HER2 protein, with emtansine, a toxic agent that kills cancer cells. Trastuzumab binds to the HER2 protein on cancer cells, and upon internalization, emtansine is released inside the cell, causing cell death.\n\n### Indications\n- **Breast Cancer**: It is primarily used to treat HER2-positive breast cancer that"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 46, "completion_tokens": 200, "total_tokens": 246}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_yjwxOs2liylmbDHdGj5VWM3i", "custom_id": "6_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "a726100febcde2461fa3752b8d7ae1a8", "body": {"id": "chatcmpl-9RR1vUwf6eYi0oRny8t0og7hdKcO3", "object": "chat.completion", "created": 1716325787, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Afatinib is a medication used in the treatment of certain types of cancer, specifically non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. Here are some key points you should know about Afatinib:\n\n1. **Mechanism of Action**: Afatinib is a type of targeted therapy known as a tyrosine kinase inhibitor (TKI). It works by inhibiting the activity of the EGFR, which is involved in the growth and spread of cancer cells. By blocking this receptor, Afatinib can help slow or stop the progression of the cancer.\n\n2. **Indications**: Afatinib is primarily used for treating metastatic NSCLC with EGFR mutations. It is important to have a genetic test to determine if your cancer has these mutations before starting treatment.\n\n3. **Administration**: Afatinib is taken orally in the form of a tablet, typically once a day. It should be taken"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 41, "completion_tokens": 200, "total_tokens": 241}, "system_fingerprint": "fp_927397958d"}}, "error": null}
{"id": "batch_req_oxh7PvK1IxGQFbVWANhLyWzh", "custom_id": "7_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "346d7bd28af62f500ba8f510400a4834", "body": {"id": "chatcmpl-9RR0xaRIl9iUaG1OuwMWrVKllH7j4", "object": "chat.completion", "created": 1716325727, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Aldesleukin, also known as interleukin-2, is a medication used to treat certain types of cancer, including metastatic kidney cancer and metastatic melanoma. Here are some important things you should know as a patient:\n\n### Indications and Uses\n- **Metastatic Renal Cell Carcinoma**: Aldesleukin is often used to treat advanced kidney cancer that has spread to other parts of the body.\n- **Metastatic Melanoma**: It is also used to treat melanoma that has spread.\n\n### Mechanism of Action\n- Aldesleukin is a recombinant form of interleukin-2, a protein that plays a role in activating the immune system. It helps stimulate the growth and activity of T-cells and other immune cells to attack cancer cells.\n\n### Administration\n- **Hospital Setting**: Aldesleukin is typically administered intravenously in a hospital setting due to its potential for serious side effects.\n- **Dosing Schedule**:"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_11XRyujndPRojSq08JIuL1nm", "custom_id": "8_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "71c7832b4db0aef5101da0f7e272ba1d", "body": {"id": "chatcmpl-9RR0xOz8IdjZFdaev0IRH7a4WD2ug", "object": "chat.completion", "created": 1716325727, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alectinib, marketed under the brand name Alecensa, is a medication used in the treatment of non-small cell lung cancer (NSCLC). Here are some important points to consider as a patient:\n\n1. **Indication**: Alectinib is primarily used for patients with NSCLC that is positive for anaplastic lymphoma kinase (ALK)-rearrangements. It is usually prescribed when the cancer is metastatic (has spread to other parts of the body).\n\n2. **Mechanism of Action**: Alectinib is a tyrosine kinase inhibitor that specifically targets and blocks the activity of the ALK protein, which is involved in the growth and spread of cancer cells.\n\n3. **Administration**: Alectinib is taken orally in capsule form, typically twice a day. It is important to take the capsules with food to enhance absorption and reduce the risk of gastrointestinal side effects.\n\n4. **Side Effects**: Common side effects include:\n   - Fatigue\n"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_SlYs7zZHguhsBsGUIKjbN7kf", "custom_id": "9_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "aec84c0adfbbb6acaa09044c907473e5", "body": {"id": "chatcmpl-9RR0xhLmiirLRTA8rIyME0v71fYhJ", "object": "chat.completion", "created": 1716325727, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Alemtuzumab is a prescription medication that is used to treat certain medical conditions by targeting specific cells in the immune system. Here are some key points you should know about Alemtuzumab as a patient:\n\n1. **Uses**:\n   - Alemtuzumab is commonly used to treat multiple sclerosis (MS), specifically relapsing forms of MS.\n   - It may also be used to treat certain types of leukemia, such as B-cell chronic lymphocytic leukemia (B-CLL).\n\n2. **Mechanism of Action**:\n   - Alemtuzumab is a monoclonal antibody that targets CD52, a protein found on the surface of certain immune cells (both T and B lymphocytes). By binding to CD52, it causes these cells to be destroyed, thereby modifying the immune response.\n\n3. **Administration**:\n   - It is usually administered via intravenous infusion (IV).\n   - The dosing schedule and duration of treatment can vary depending on the condition being treated"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 42, "completion_tokens": 200, "total_tokens": 242}, "system_fingerprint": "fp_729ea513f7"}}, "error": null}
{"id": "batch_req_wKxM1OPqlMZYncG5jaK1ojv0", "custom_id": "10_sentiment_question_patient_1.0_gpt-4o", "response": {"status_code": 200, "request_id": "ba687a008275554c3b36f291b1ed6dda", "body": {"id": "chatcmpl-9RR0x1HdRE8nydB4znrTYJmx5wKgw", "object": "chat.completion", "created": 1716325727, "model": "gpt-4o-2024-05-13", "choices": [{"index": 0, "message": {"role": "assistant", "content": "All-trans retinoic acid (ATRA), also known as tretinoin, is a medication primarily used in the treatment of acute promyelocytic leukemia (APL) and certain skin conditions, including severe acne and fine wrinkles. Here are some important points you should know about ATRA:\n\n### Medical Uses\n1. **Acute Promyelocytic Leukemia (APL)**: ATRA is used in combination with other medications to treat APL, a subtype of acute myeloid leukemia. It helps promote the differentiation of immature blood cells into mature ones.\n2. **Skin Conditions**: Topically, it is used to treat acne, reduce fine wrinkles, and improve skin texture. It works by promoting the turnover of skin cells and reducing the formation of acne lesions.\n\n### How It Works\n- **Mechanism**: ATRA is a derivative of vitamin A. It works by binding to nuclear receptors and influencing gene expression, promoting the differentiation and growth of cells.\n\n### Administration\n"}, "logprobs": null, "finish_reason": "length"}], "usage": {"prompt_tokens": 44, "completion_tokens": 200, "total_tokens": 244}, "system_fingerprint": "fp_927397958d"}}, "error": null}
